7-Hydroxy-4-methyl-2-oxo-2H-chromene-8-carbaldehyde
Title | Journal |
---|---|
Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity. | Journal of medicinal chemistry 20140522 |
Synthesis, spectroscopic characterization and biological evaluation studies of Schiff's base derived from naphthofuran-2-carbohydrazide with 8-formyl-7-hydroxy-4-methyl coumarin and its metal complexes. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20121201 |
8-Formyl-4-methyl-2-oxo-2H-chromen-7-yl 4-methyl-benzenesulfonate. | Acta crystallographica. Section E, Structure reports online 20110601 |
Synthesis, physico-chemical investigations of Co(II), Ni(II) and Cu(II) complexes and their in vitro microbial, cytotoxic, DNA cleavage studies. | Journal of enzyme inhibition and medicinal chemistry 20100601 |
DNA cleavage and in vitro antimicrobial studies of Co(II), Ni(II), and Cu(II) complexes with ONNO donor Schiff bases: synthesis, spectral characterization, and electrochemical studies. | Journal of enzyme inhibition and medicinal chemistry 20100201 |
Synthesis, characterization, DNA cleavage and in vitro antimicrobial studies of La(III), Th(IV) and VO(IV) complexes with Schiff bases of coumarin derivatives. | European journal of medicinal chemistry 20090701 |
Synthesis, spectral characterization, in vitro microbial and cytotoxic studies of lanthanum(III) and thorium(IV) complexes with 1,2,4-triazole Schiff bases. | Journal of enzyme inhibition and medicinal chemistry 20090601 |
Synthesis, spectral characterization and in vitro biological studies of Co(II), Ni(II) and Cu(II) complexes with 1,2,4-triazole Schiff bases. | Journal of enzyme inhibition and medicinal chemistry 20090401 |
Synthesis, spectral characterization, in vitro antibacterial, antifungal and cytotoxic activities of Co(II), Ni(II) and Cu(II) complexes with 1,2,4-triazole Schiff bases. | European journal of medicinal chemistry 20081201 |
Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationships. | Journal of medicinal chemistry 20080227 |